Sign In
Buy KVUE
$19.24
-0.0700 (-0.363%)
At Close: Jul 31, 2026
Kenvue's Q2 Earnings Coming Up: Here's What Lies Ahead of the Stock
02:26pm, Friday, 31'st Jul 2026
KVUE is expected to post Q2 revenue and earnings growth as brand strength, innovation and productivity efforts offset seasonal and cost pressures.
Kenvue Benefits From Consumer Health Trends and Margin Expansion
11:41am, Wednesday, 29'th Jul 2026
Kenvue's beauty momentum, margin expansion and stronger cash flow support its outlook as uneven demand and deal uncertainty temper visibility.
Is Kenvue Stock Attractive After Margin Gains and Deal Uncertainty
11:41am, Wednesday, 29'th Jul 2026
KVUE's margin gains and stronger cash flow boost its appeal, but slow organic growth, debt and deal uncertainty keep the outlook balanced.
Kenvue's Brand Strength and Growth Drivers Shape Its Future Outlook
11:41am, Wednesday, 29'th Jul 2026
KVUE's trusted brands, margin gains and pending Kimberly-Clark deal shape its outlook amid mixed growth signals.
Kenvue Increases Quarterly Cash Dividend
06:45am, Wednesday, 29'th Jul 2026
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock, which represents a 1.2 percent
5 Dividend Kings Continued to Pay and Raise Dividends Through Every Market Crash Since Black Monday
08:20am, Monday, 27'th Jul 2026
Black Monday was on Monday, October 19, 1987, almost 40 years ago, and market veterans and long-time investors usually mention one important item: nobody really saw it coming or expected it.
Kenvue Inc. $KVUE Shares Acquired by Gabelli Funds LLC
04:27am, Monday, 27'th Jul 2026
Gabelli Funds LLC increased its stake in Kenvue Inc. (NYSE: KVUE) by 71.2% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 724,635 shares of the
Analysts Set Kenvue Inc. (NYSE:KVUE) Price Target at $19.58
01:45am, Sunday, 26'th Jul 2026
Kenvue Inc. (NYSE: KVUE - Get Free Report) has been given an average recommendation of "Hold" by the sixteen research firms that are covering the firm, MarketBeat.com reports. Thirteen equities resear
US FDA approves over-the-counter Tylenol combination pill for pain relief
12:00pm, Friday, 24'th Jul 2026
The U.S. Food and Drug Administration on Friday approved a nonprescription, fixed-dose pill that combines Kenvue's Tylenol with the nonsteroidal anti-inflammatory drug naproxen for up to 12 hour
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026
06:45am, Thursday, 23'rd Jul 2026
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its second quarter 2026 financial results before the market opens on August 6, 2026. Due to the pending transaction with Kimberly-
An Overlooked Dividend King With a 54-Year Winning Streak Worth Buying Now
11:30am, Monday, 20'th Jul 2026
This Dividend King just made a major strategic pivot.
US appeals court revives private lawsuits linking Tylenol to autism, ADHD
10:54am, Monday, 13'th Jul 2026
A federal appeals court on Monday revived hundreds of private lawsuits against Kenvue and many pharmacies and retailers, alleging that the Tylenol painkiller causes autism and att
This 4.5%-Yielding Dividend Stock Is Beating the S&P 500 and the Nasdaq. 3 Reasons That Can Continue in the Second Half of 2026
08:05am, Wednesday, 08'th Jul 2026
Kimberly-Clark is far from flashy, but what it lacks in glitz and glam, it makes up for with predictability.
2 Dividend Kings to Buy and Hold Forever
06:00am, Wednesday, 08'th Jul 2026
Dividend Kings are companies that have increased their dividend payments for at least 50 consecutive years. Automatic Data Processing has seen its share price drop over concerns about unemployment.
3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now
01:19pm, Tuesday, 07'th Jul 2026
Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare setup: quality names trading in single-digit and low-double-digit territory while still throwing off ca
